{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:15:12Z","timestamp":1779164112115,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1136\/ijgc-2024-005416","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T01:15:23Z","timestamp":1713921323000},"page":"1366-1372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Predicting the Risk of nOdal disease with histological and Molecular features in Endometrial cancer: the prospective PROME trial"],"prefix":"10.1016","volume":"34","clinical-trial-number":[{"clinical-trial-number":"nct05793333","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05793333","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8373-8569","authenticated-orcid":false,"given":"Giorgio","family":"Bogani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Lalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jvan","family":"Casarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Ghezzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Chiappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Fanfani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2758-1063","authenticated-orcid":false,"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Raspagliesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2024-005416_bb0010","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2024-005416_bb0015","doi-asserted-by":"crossref","first-page":"102468","DOI":"10.1016\/j.canep.2023.102468","article-title":"Cancers attributable to overweight and obesity in Italy","volume":"87","author":"Di Maso","year":"2023","journal-title":"Cancer Epidemiol"},{"key":"10.1136\/ijgc-2024-005416_bb0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2024-005416_bb0025","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","article-title":"Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Oaknin","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2024-005416_bb0030","article-title":"Lymphadenectomy for the management of endometrial cancer","volume":"10","author":"Frost","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/ijgc-2024-005416_bb0035","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(09)62002-X","article-title":"Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis","volume":"375","author":"Todo","year":"2010","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2024-005416_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygyno.2022.10.017","article-title":"Sentinel lymph node mapping in patients with endometrial hyperplasia: a practice to preserve or abandon","volume":"168","author":"Mueller","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005416_bb0045","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2021.05.009","article-title":"Sentinel lymph node biopsy in patients with endometrial cancer and an indocyanine green or iodinated contrast reaction - a proposed management algorithm","volume":"162","author":"Zammarrelli","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005416_bb0050","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ygyno.2019.02.027","article-title":"Low-volume disease in endometrial cancer: the role of micrometastasis and isolated tumor cells","volume":"153","author":"Bogani","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005416_bb0055","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"500","author":"Network","year":"2013","journal-title":"Nature"},{"key":"10.1136\/ijgc-2024-005416_bb0060","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of promise: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2024-005416_bb0065","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2024-005416_bb0070","doi-asserted-by":"crossref","first-page":"107269","DOI":"10.1016\/j.ejso.2023.107269","article-title":"Characteristics and outcomes of surgically staged multiple classifier endometrial cancer","volume":"50","author":"Bogani","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"10.1136\/ijgc-2024-005416_bb0075","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/ijgc-2023-004864","article-title":"Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review","volume":"34","author":"De Vitis","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2024-005416_bb0080","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ijgo.15266","article-title":"Letter to the editor: 2023 FIGO staging system for endometrial cancer","volume":"164","author":"Raspagliesi","year":"2024","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2024-005416_bb0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/ijgc-2023-005032","article-title":"Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional study","volume":"34","author":"Cucinella","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2024-005416_bb0090","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ejso.2023.02.006","article-title":"Hysterectomy alone vs. hysterectomy plus sentinel node mapping in endometrial cancer: perioperative and long-term results from a propensity-score based study","volume":"49","author":"Bogani","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"10.1136\/ijgc-2024-005416_bb0095","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ygyno.2022.01.025","article-title":"Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases","volume":"165","author":"Jamieson","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005416_bb0100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ygyno.2004.06.042","article-title":"High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy","volume":"95","author":"Mariani","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005416_bb0105","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ygyno.2003.11.032","article-title":"Endometrial carcinoma: paraaortic dissemination","volume":"92","author":"Mariani","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005416_bb0110","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ygyno.2021.06.031","article-title":"Oncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: an international multi-institutional study","volume":"162","author":"Ghoniem","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005416_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2008.01.023","article-title":"Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging","volume":"109","author":"Mariani","year":"2008","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24035539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24035539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2024-005416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T01:53:56Z","timestamp":1756691636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24035539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1048891X24035539"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2024-005416","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting the Risk of nOdal disease with histological and Molecular features in Endometrial cancer: the prospective PROME trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2024-005416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}